Ovary Syndrome Has Been Renamed Internationally
The condition formerly known as polycystic ovary syndrome is now called polyendocrine metabolic ovarian syndrome.
Updated on Sept. 22, 2026 in Women’s Health
Live Poll
Do you feel confident that updated medical terminology helps doctors better identify and treat your symptoms?
An international panel of physicians, researchers, and patient advocates has renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome. The change aims to better reflect the condition's wide-ranging impact on the body.
Why it matters
Updating the terminology incorporates metabolic and endocrine features into the name to emphasize the full-body nature of the disorder. Experts hope the new name will improve recognition and reduce the high rate of undiagnosed cases.
The condition affects at least 1 in 10 women in the United States, with an estimated 50% of these cases remaining undiagnosed. The disorder is clinically linked to insulin resistance, obesity, type 2 diabetes, fatty liver disease, and cardiovascular disease.
The players
International panel of physicians, researchers, and patient advocates
This group of global health professionals and advocates is responsible for updating medical nomenclature to align with current clinical understanding.
The details
The condition, which can cause infertility, irregular periods, and ovarian cysts, is also associated with elevated androgen levels that contribute to acne and hair changes. By shifting the name, advocates intend to highlight the systemic metabolic and endocrine issues that define the syndrome beyond just ovarian symptoms.
Timeline
September 22, 2026: The medical renaming was officially announced.
Health Landscape
The renaming of polyendocrine metabolic ovarian syndrome marks a departure from the diagnostic naming conventions established by the 2003 Rotterdam criteria. This shift reflects a broader evolution in medical science toward recognizing how metabolic and endocrine health are deeply interconnected.
Patients should discuss these updated clinical labels with their healthcare providers to ensure their medical records reflect the latest understanding of the condition. Recognizing these broader metabolic symptoms may help individuals better manage related risks like insulin resistance and diabetes.
The takeaway
Patients who experience irregular periods or hormonal changes should consult with a doctor to discuss potential metabolic links. Increased awareness of the new name may assist in securing earlier diagnosis for the millions of women currently living undiagnosed.
Further reading
Learn more about the latest updates in Women’s Health.
More information
To schedule a consultation or learn about diagnostic services, visit the LVHN appointment request portal.
Source note: This article includes information reported by TNonline.
Live Poll
Do you feel confident that updated medical terminology helps doctors better identify and treat your symptoms?
